 Connection
Alvaro Martinez-Camacho to Humans
This is a "connection" page, showing publications Alvaro Martinez-Camacho has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.060 |
|
|
|
-
Bryant A, Kalra A, Truesdale A, Pyle L, Martinez-Camacho A. Favorable Sustained Virologic Response Rates Using Direct-Acting Antiviral Therapies at a Large Safety-Net Hospital. J Health Care Poor Underserved. 2020; 31(3):1213-1227.
Score: 0.019
-
Nordstrom EM, Keniston A, Baouchi F, Martinez-Camacho A. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety. Eur J Gastroenterol Hepatol. 2017 Jan; 29(1):10-16.
Score: 0.015
-
Martinez-Camacho A, Fortune BE, Gralla J, Bambha K. Early weight changes after liver transplantation significantly impact patient and graft survival. Eur J Gastroenterol Hepatol. 2016 Jan; 28(1):107-15.
Score: 0.014
-
Ismail MS, Hassan M, Martinez-Camacho A, May SB, Goss JA, Kanwal F, Jalal PK. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int. 2020 08; 33(8):925-935.
Score: 0.005
-
Fortune BE, Martinez-Camacho A, Kreidler S, Gralla J, Everson GT. Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation. Transpl Int. 2015 Aug; 28(8):980-9.
Score: 0.003
-
Goldberg DS, Camp A, Martinez-Camacho A, Forman L, Fortune B, Reddy KR. Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis. Liver Transpl. 2013 Mar; 19(3):250-8.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|